| A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells A Zahabi, E Shahbazi, H Ahmadieh, SN Hassani, M Totonchi, A Taei, ... Stem cells and development 21 (12), 2262-2272, 2012 | 85 | 2012 |
| GDF15, an update of the physiological and pathological roles it plays: A review A Assadi, A Zahabi, RA Hart Pflügers Archiv - European Journal of Physiology, 2020 | 82 | 2020 |
| Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation B Dannenmann, A Zahabi, P Mir, B Oswald, R Bernhard, M Klimiankou, ... Experimental hematology 71, 51-60, 2019 | 20 | 2019 |
| Interactions of human embryonic stem cell-derived neural progenitors with an electrospun nanofibrillar surface in vitro A Rahjouei, S Kiani, A Zahabi, NZ Mehrjardi, M Hashemi, H Baharvand The International journal of artificial organs 34 (7), 559-570, 2011 | 20 | 2011 |
| Regenerative therapy for retinal disorders N Daftarian, S Kiani, A Zahabi Journal of ophthalmic & vision research 5 (4), 250, 2010 | 18 | 2010 |
| iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia B Dannenmann, M Klimiankou, B Oswald, A Solovyeva, J Mardan, ... Cell Stem Cell 28 (5), 906-922. e6, 2021 | 16 | 2021 |
| Thrombopoietin induces hematopoiesis from mouse ES cells via HIF‐1α–dependent activation of a BMP4 autoregulatory loop A Pramono, A Zahabi, T Morishima, D Lan, K Welte, J Skokowa Annals of the New York Academy of Sciences 1375 (1), 38-51, 2016 | 14 | 2016 |
| NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells Y Xu, M Nasri, B Dannenmann, P Mir, A Zahabi, K Welte, T Morishima, ... Stem Cell Research & Therapy 12, 1-14, 2021 | 11 | 2021 |
| SIRT2 Plays Essential Role in Early Hematopoiesis through Deacetylation of LMO2 Protein T Morishima, R Bernhard, A Zahabi, B Dannenmann, M Nasri, B Samareh, ... Blood, The Journal of the American Society of Hematology 126 (23), 3574-3574, 2015 | 2 | 2015 |
| BAALC Is a Key Mediator of Leukemia Development in Congenital Neutropenia B Dannenmann, M Klimiankou, A Solovyeva, A Zahabi, P Mir, M Nasri, ... Blood 130 (Supplement 1), 541-541, 2017 | 1 | 2017 |
| Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring ELANE mutations A Zeidler, N Borbaran-Bravo, B Dannenmann, M Ritter, M Nasri, ... Haematologica 109 (5), 1393-1402, 2024 | | 2024 |
| Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells Y Xu, M Nasri, B Dannenmann, P Mir, A Zahabi, K Welte, T Morishima, ... Stem Cell Research & Therapy 14 (1), 299, 2023 | | 2023 |
| iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia B Dannenmann, M Klimiankou, B Oswald, A Solovyeva, J Mardan, ... Cell Stem Cell 30 (9), 1282, 2023 | | 2023 |
| Corrigendum to ‘Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation’<[Experimental … B Dannenmann, A Zahabi, P Mir, B Oswald, R Bernhard, M Klimiankou, ... Experimental Hematology 114, 61, 2022 | | 2022 |
| A New Efficient Protocol for Directed Differentiation of Retinal Pigmented Epithelial Cells from Normal and Retinal Disease Induced Pluripotent Stem Cells (vol 21, pg 2262, 2012) A Zahabi STEM CELLS AND DEVELOPMENT 30 (24), 1241-1242, 2021 | | 2021 |
| Establishment of an in vitro model of leukemogenic transformation in congenital neutropenia (CN) using patient derived iPSCs JS Benjamin Dannenmann, Maksim Klimiankou, Annna Solovjeva, Regine Bernhardt ... Experimental Hematology 53, 2017 | | 2017 |
| An in vitro model of leukemogenic transformation in congenital neutropenia (CN) using patient derived iPSCs B Dannenmann, M Klimiankou, A Solovjeva, R Bernhardt, T Morishima, ... ONCOLOGY RESEARCH AND TREATMENT 40, 18-18, 2017 | | 2017 |
| Establishment of an in vitro model of leukemogenic transformation in congenital neutropenia (CN) using patient derived iPSCs B Dannenmann, M Klimiankou, A Solovjeva, R Bernhardt, T Morishima, ... Experimental Hematology 53, S113, 2017 | | 2017 |
| NAMPT-NAD+-SIRT2-triggered deacetylation of LMO2 protein is indispensable in the early hematopoiesis through TAL1 complex formation T Morishima, C Lindner, R Bernhard, A Zahabi, B Dannenmann, M Nasri, ... ONCOLOGY RESEARCH AND TREATMENT 40, 19-19, 2017 | | 2017 |
| Modeling of hematopoiesis using ES and patients-derived iPS cells A Zahabi Universität Tübingen, 2017 | | 2017 |
Julia SkokowaHead Division of Translational Oncology, Department of Hematology, Oncology and Clinical Immunology, University Hospital Tuebingen, GermanyVerified email at med.uni-tuebingen.de
